Dr. Nilanjana Maulik is a Professor of Molecular Cardiology and heading the Angiogenesis Laboratory at the Department of Surgery, UConn Health, Farmington, Connecticut. Prof. Maulik received her Ph.D. in Biochemistry in December 1990 from Calcutta University, India. After completion of her Ph.D., Prof. Maulik joined the Department of Surgery at UConn Health as a research fellow and continued as a faculty where now she serves as Tenured Professor. She is heavily involved in NIH funded research and serves as one of the experts in the angiogenesis field in the NIH study sections and has given more than 100 invited lectures both nationally and internationally. Prof. Maulik is also member of several prestigious societies, such as FASEB, AHA, ISHR, American College of Nutrition (ACN), International College of Angiology (ICA). She was the member of the Myocardial Ischemia Metabolism (MIM) study section of NIH for last 6 years and of the NHLBI Program Project Review Committee. Presently, Prof. Maulik serves as a reviewer of a several special emphasis panel study section of NIH. She is also a reviewer of the AHA Grant review process. She is on several Editorial boards of major cardiovascular journals. She is an associate editor of Molecular Cellular Biochemistry journal. Teaching is an integral part of her professional path. She is a recipient of several prestigious awards including Faculty Recognition award from the University of Connecticut Health Center. Her research focuses on the molecular mechanism of myocardial angiogenesis in the diseased/infarcted heart, ischemia/reperfusion injury, apoptosis and on the development of cardioprotective strategies which includes gene and stem cell therapy. She has published 170 original peer reviewed articles and 35 book chapters and very recently (2010) she has edited a book on epigenetics and human diseases for CRC press. Prof. Maulik has organized several international conferences/symposia, etc.

Education

Degree	Institution	Major
BSc	St. Xavier's College	Chemistry (Hons)
MSc	University of Calcutta	Biochemistry
PhD	University of Calcutta	Biochemistry
PhD	University of Connecticut School of Medicine	Molecular Cardiology

Awards

Name of Award/Honor	Awarding Organization
Finalist, Research Innovation and Leadership, October 14th, 2021	17th Annual Women of Innovation
Fellow of American College of Nutrition	American College of Nutrition
Faculty Recognition Award	University of Connecticut Health
Fellow of American Heart Association	American Heart Association
Best Oral Presentation	Randox Award at International Society for Free Radical Research
Grant-In-Aid	American Heart Association
Young Investigator	American College of Angiology
Post Doctoral Fellowship	American Heart Association

Name & Description	Category	Role	Type	Scope	Start Year	End Year
Scholarship and Promotion Committee, Department of Surgery	Advisory Committee	Member	UConn Health	University	2019	2024
NIH study Section ZGMI RCB-5(SC) served in June 11th,2019	Study Section	Reviewer	External	National	2019	2019
NIH study section-ZGMI RCB-5(SC), October 11th , 2019	Study Section	Reviewer	External	National	2019	2019
British Heart Foundation Grants	Research Committee	Reviewer	External	International	2019	2019
Society for Redox Biology and Medicine (SFRBM), 2019	Education Committee	Reviewer	External	International	2019	2019
Cardiovascular Diabetology	Professional/Scientific Journal	Reviewer	External	International	2019
Center European J of Immunology	Professional/Scientific Journal	Reviewer	External	International	2019
J of Pain Research	Professional/Scientific Journal	Reviewer	External	International	2019	2019
Theranostics	Professional/Scientific Journal	Reviewer	External	International	2019	2019
Medical Curriculum Evaluation Committee (CEC)	Advisory Committee	Member	UConn Health	University	2018	2023
Group of Women in Medicine and Science (GWIMS)	Advisory Committee	Member	UConn Health	University	2017	2023
Experimental Biology and Medicine	Professional/Scientific Organization	Adhoc Reviewer	External	International	2015
Expert Opinion on Biological Therapy	Professional/Scientific Journal	Adhoc Reviewer	External	International	2015
Editor-In-Chief for the special Issue "Antioxidants in Longevity and Medicine" in the Journal Oxidative Medicine and Longevity	Editorial Board	Editor-In-Chief	External	International	2014	2014
Molecular Biology Reports	Editorial Board	Editor-In-Chief	External	International	2013	2020
Editor-In-Chief for the special Issue "Antioxidants in Longevity and Medicine" in the Journal Oxidative Medicine and Longevity	Professional/Scientific Journal	Editor-In-Chief	External	International	2013	2013
International Conference on Natural Products in Health and 25th Annual Conference of The Indian Society for Atherosclerosis Research, Annamalai University, Annamalainagar, Tamilnadu, India	Professional/Scientific Organization	Organizer	External	International	2012
International Academy of Cardiology Annual Scientific Session	Advisory Committee	Advisor	External	International	2012	2023
International Society for Free Radicals (SFRR)	Professional/Scientific Organization	Advisory Committee	External	International	2011
PLoS ONE	Other	Reviewer	External	International	2010
International Academy of Cardiovascular Sciences, University of Mannitoba, St. Boniface General Hospital Research Center, Canada.	Professional/Scientific Organization	Fellow	External	International	2008	2022
Circulation	Other		External	International	2004
Society for Free Radical Research (SFRR)	Professional/Scientific Organization	Advisor	External	International	2004	2026
American Heart Association	Professional/Scientific Organization	Fellow of American Heart	External	International	2004
Journal of Cellular Molcular Medicine	Other	Reviewer	External	International	2003
NIH Study SEction	Study Section	Reviewer	External	National	2003	2020
The American Physiological Society	Professional/Scientific Organization	Member		International	2002	2020
Molecular Cellular Biochemistry	Editorial Board	Associate Editor	External	International	2001	2025
Antioxidant Redox Signaling	Editorial Board	Editorial Board Member	External	International	2000	2030
Diabetes	Other	Reviewer		International	2000
Antioxidant Redox Signaling	Editorial Board	Reviewer	External	International	2000
American Journal of Physiology	Professional/Scientific Journal	Adhoc Reviewer	External	National	2000
American Heart Association	Professional/Scientific Organization	Premium Professional Silver Heart Member	External	International	1998
Graduate Program Committee (Vascular and Cell Biology)	Education Committee	Faculty	UConn Health	University
Nanomedicine	Professional/Scientific Journal	Adhoc Reviewer		International

Inspite of significant improvements in its medical and surgical management Ischemic Heart Disease (IHD) is still the leading cause of morbidity and mortality in the western world. The health care system of the modern world has come up with good therapeutic methods, in time, to fight the devastating effects of the disease but it doesn’t seem to be enough to tackle still many aspects of the disease. Now the pressure is even greater on basic scientists and clinicians to deliver their best to translate their knowledge from bench to bedside.

Dr Maulik and her team is dedicated to bring about better understanding of the molecular mechanisms that govern the pathology of IHDs and the processes of angiogenesis and arteriogenesis in cellular and animal models of heart disease and to apply this basic knowledge obtained to tackle this dreaded disease by employing newer and better therapeutic approaches to protect, rescue, repair or regenerate the myocardium from ischemia induced myocardial degeneration and failure.

The process of cellular regeneration and repair which leads to reconstruction of structural and functional normal tissue in an injured area is undoubtedly highly efficient in embryos. However this ability is lost at the time of birth. During the fetal life both tissue repair refer to an identical biological response to injury, however, after birth they refer to two distinct biological processes. In the case of tissue repair, an injury results in repair and scar formation in all organs while on the other hand regeneration implies the replacement of dead cells by newly formed cells that differentiate and organize aiding in the restoration of the original structure of the lost tissue. This process of tissue regeneration occurs during the normal physiological cell turnover process, however in the absence of injury.

Several attempts have been made to promote cardiac regeneration in the infarcted ventricle. However despite many efforts to unearth a suitable strategy, the most appropriate form of myocardial regeneration therapy after myocardial injury remains to be identified. Over the past few years the better understanding of the biology of vasculogenesis, angiogenesis and arteriogenesis has significantly increased the use of growth factors in the treatment and/or prevention ischemic heart disease by inducing blood vessel formation and thereby restoring/enriching the blood flow. Therapeutic angiogenesis makes use of the administration of a drug or angiogenic growth factor protein or gene to promote the development of endogenous collateral vessels in ischemic myocardium. Gene transfer and protein therapy are the two main approaches that have been used to achieve therapeutic angiogenesis. Most recently, interest has grown in the potential of cell-based gene transfer to induce myocardial angiogenesis and arteriogenesis. It has been established in many preclinical studies that bone marrow cells may be able to secrete multiple potentially angiogenic substances as well as differentiate into cells that create new blood vessels. But the concept of myogenesis is not far behind as it is known that there may be dedicated precursors of cardiomyocytes in the myocardium, however, it seems to be little bit more far fetched in relation to the differentiation of bone-marrow-derived cells into heart muscle cells. It still remains elusive whether the transplanted cells themselves differentiate, or whether the paracrine effects from these transplanted cells stimulate already resident stem cells in the heart to differentiate.

Dr. Maulik’s research strategy combines expertise in different model systems to study IHD and the processes of angiogenesis and arteriogenesis, in vitro (cell culture), ex vivo (Langendorff and working heart model of myocardial global ischemia) and in vivo (rat and mouse survival surgery/LAD occlusion model myocardial regional ischemia) along with the various molecular biology techniques, proteomics, genomics, immunohsitochemical technique, small animal echocardiographic analysis and other imaging techniques that are made available to the fellows. Her laboratory also have expertise in non-invasive administration of drugs, adenovirus associated gene transfer and cell-based gene transfer to the myocardium to study the effect of inducing or turning off genes of interest in the process or angiogenesis, arteriogenesis and myocardial regeneration.

Her laboratory currently focuses on:

1) Molecular and cellular signaling during myocardial ischemia and reperfusion.
2) Mechanism of pharmacological as well as ischemic preconditioning of the heart.
3) Pharmacological preconditioning of sick hearts as in the case diabetes, hypertension, hypercholesterolemia etc.
4) The role of ubiquitination and proteasomal degradation of different proteins in sick hearts.
5) Impairment of myocardial angiogenesis in diabetes: How to cope and Thrive
6) Adenovirus associated gene transfer and cell-based gene transfer to study the effect of inducing or turning off genes of interest in the process of myocardial regeneration.
7) Molecular mechanism of angiogenesis and arteriogenesis in hind limb ischemia model.

Science is quickening its pace towards better ideas in every field it has stepped into, particularly in the field of medicine. A time may not be far when we might be able to effectively cure IHD. But, “prevention is always better than cure”.

Accepting Lab Rotation Students: Fall Block 2024, Spring 2 Block 2025

Journal Articles

Books

Book Chapters

Abstracts

Editorials

Letters

Other

Reviews

Short Surveys

Title or Abstract	Type	Sponsor/Event	Date/Year	Location
Integration of hydrogel loaded with Mesenchymal Stem Cells Overexpressing Thioredoxin-1 as a Promising Clinical Patch to Repair and Regenerate Ischemic Tissue in Hind Limb Ischemia Model	Talk	2023, Clinical Congress, ACS, Boston	2023	Clinical Congress, ACS, Boston, MA
Recovery from multiple organ dysfunction syndrome by exosome therapy	Talk	2023, 55th Scientific and Annual Meeting (CTACSPA), 13th October,2023, Trumbull, CT	2023	55th, Scientific and Annual Meeting (CTACSPA), 13th October,Trumbull, CT
Genetic Approach to demonstrate the Cardioprotective function of E3 ligase after Myocardial Infarction	Talk	2023, 55th Scientific and Annual Meeting (CTACSPA), 13th October,2023, Trumbull, CT	2023	55th, Scientific and Annual Meeting (CTACSPA), 13th October,Trumbull, CT
Improved Engineered Stem Cell Transplantation along with Hydrogel as a Suitable Platform to Repair and Regenerate Ischemic Tissue in a Hind Limb Ischemia Model	Talk		2023	NESS Annual Meeting, 2023
Role Of Cardiomyocyte Specific Pellino-1, An E3 Ligase On Therapeutic Angiogenesis And Attenuation Of Ventricular Remodeling In A Murine Myocardial Infarction Model.	Poster	Basic cardiovascular Sciences Scientific Sessions	2023	Basic cardiovascular Sciences Scientific Sessions, Boston, MA
Small Extracellular Vesicles in the Management of Wound Healing:Andrew Kemerley, DO, Sue Ting-Lim, MD, Diego Accorsi, MD, Ajayan Mannoor Supran, PhD, Priscilla Lam, MD, Santosh Swaminathan, MD, Mahesh Thirunavukkarasu, PhD, David McFadden, MD, FACS, J. Alexender Palasty, MD, Nilanjana Maulik, PhD, FAHA	Lecture		2022	Connecticut Chapter of ACS, Annual meeting, Providence, RI
Extracellular Vesicle Derived from TRX-1 Overexpressed Mice Ameliorates Pathological wound healing and promotes angiogenesis in a murine ischemic wound model:	Lecture		2022	Clinical Congress American College of Surgeons, San Diego
Thioredoxin-1 Engineered Exosomes: A New Tool to Stimulate Revascularization and Regeneration of Ischemic Tissue by Decreasing Fibrosis, Increasing Blood Perfusion and Vessel Density in a Murine Model of Hind-Limb Ischemia.	Talk		2020	Virtual, AHA Scientific Session,
Cardiomyocyte Specific Pellino1 Knockout Leads to Increased Oxidative Stress, Reduced Anti-apoptotic Signaling and Cardiac Dysfunction in a Murine Myocardial Infarction Model. Scientific	Talk		2020	Virtual, AHA Scientific Session,
Cardiomyocyte Specific Overexpression of Pellino-1 Reverses Sepsis induced Cardiac Dysfunction in a Murine Model by Reducing Inflammatory Response and Cardiac Cell Death,	Talk		2020	Virtual, American College of Surgeons, Clinical Congress
Gene Therapy with Pellino-1 Improves Perfusion and Decreases Tissue Loss in an Flk-1 Heterozygous Murine Hind Limb Ischemia Model But Fails In MAPKAPKinase2 Knockout Mice	Talk		2020	Virtual, American College of Surgeons, Clinical Congress
Overexpression of Pellino-1 in Cardiomyocytes Limits Systemic Inflammation, Cardiac Cell Death and Preserves Cardiac Function in a Murine Sepsis Model.	Talk		2020	Virtual, Connecticut Chapter of the Amecican College of Surgeons
Cardiomyocyte Specific Overexpression of Pellino-1 Reverses Sepsis induced Cardiac Dysfunction in a Murine Model by Reducing Inflammatory Response and Cardiac Cell Death.	Talk	American Heart	2020	American Heart Association, Scientific Session
Gene Therapy with Pellino-1 Improves Perfusion and Decreases Tissue Loss in an Flk-1 Heterozygous Murine Hind Limb Ischemia Model But Fails In MAPKAPKinase2 Knockout Mice.	Talk	American Heart	2020	American Heart Association, Scientific Session
Overexpression of Pellino-1 in Cardiomyocytes Limits Systemic Inflammation, Cardiac Cell Death and Preserves Cardiac Function in a Murine Sepsis Model.	Talk	Connecticut Chapter of the Amecican College of Surgeons	2020	Connecticut Chapter of the Amecican College of Surgeons
Use of Engineered Exosomes Isolated from Thioredoxin-1 Overexpressed Mice Subjected to Cecal Ligation and Puncture Leads to Prolonged Survival following Severe Sepsis	Talk	American College of Surgeons Committee on Trauma(CoT) Region	2020	American College of Surgeons Committee on Trauma(CoT) Region
Isolation and Characterization of Thioredoxin-1 Engineered Exosomes and its Role in Cardiac Function Following Myocardial Infarction	Talk		2019	NESS 26th Annual Day, Waltham, MA
Injection of Exosomes Isolated from Thioredoxin-1 Overexpressed Mice Leads to Improved Cardiac Function and Decreased Fibrosis after Myocardial Infarction.	Talk		2019	American College of Surgeons, Clinical Congress.
Bioengineered Nanofiber Scaffold Induces Healthy Wound Healing in a Murine Ischemic Full-thickness wound model	Talk		2019	Anaheim California
Angiogenic Response in Ischemic Tissue	Lecture	Society of Free radical Research	2018	Delhi, India
Therapeutic Angiogenesis in Ischemic Heart	Talk	Gangaram Hospital	2018	Delhi, India
VEGF in Wound Repair	Talk	Jadavpur University	2018	Kolkata, India
Regulation of Angiogenic Response in Diabetic Myocardium	Plenary Lecture	World Congress Cardiology	2018	Boston
CARDIOVASCULAR PROTECTION, REPAIR AND REGENERATION	Other	World Congress Cardiology	2018	Boston
Bioengineered Nanofiber Scaffold Loaded with Resveratrol Improves Cardiac Function Following Myocardial Infarction After Four Weeks	Talk	25th Annual NESS Presentation Day	2018	Waltham Woods in Waltham, Massachusetts
Utilization of a Novel Engineered Nanofibrous Scaffold Loaded with Resveratrol in a Preclinical Full Thickness Wound Model in Mice	Talk	25th Annual NESS	2018	Waltham Woods in Waltham, Massachusetts
New Molecular Targets of VEGF Signaling in Cardiovascular Disease.	Lecture	IACS, North America	2017	Orlando, Florida
Proangiogenic Molecules in Cardiac Disease:	Lecture	International Society of Heart Research Conference	2017	Chennai, India
Cardiac Disease and its Therapy	Other	IACS, North America	2017	Orlando, Florida
Group Lecture on "VEGF Signaling in Cardiovascular System".	Other	University of Calcutta	2017	Calcutta, India
Bioengineered Nanofiber Scaffold Loaded with Resveratrol Improves Cardiac Function Following Myocardial Infarction: Our Preliminary Findings.	Talk	Connecticut Chapter of the American College of Surgeons	2017	Connecticut
Pellino-1 Overexpression in Cardiomyoctes Enhances Cardiac Function and Attenuates Ventricular Remodeling in Murine Myocardial Infarction Model.	Talk	American College of Surgeons	2017	San Diego, CA
Cardiac Regeneration and Repair	Other	International Academy of Cardiovascular Sciences	2016	Sherbrooke, Quebec, Canada
New Molecular Targets of VEGF Signaling in Cardiovascular Disease,	Lecture	International Academy of Cardiovascular Sciences	2016	Sherbrooke, Quebec, Canada
Regeneration of Infarcted myocardium by genetically modified stem cells.	Plenary Lecture	Stem cell congress	2016	Manchester, UK
Stem Cell in tissue repair and regeneration	Other	Stem Cell Congress	2016	Manchester, UK
Thioredoxin-1 Overexpression in mice decreases sepsis-induced cardiac failure	Talk	Society of Black Academic Surgeons	2016	Columbus, Ohio
Adeno-HSPA12B Delivery Improves Neovascularization in a Murine Model of Hind Limb Ischemia	Poster	American Heart Scientific Session	2016	New Orleans
Pellino1 is Required to Preserve Myocardial Function and Promote Neovascularization in the Infarcted Myocardium	Poster	American Heart Scientific Session	2016	New Orleans
Thioredoxin-1 Augments Wound Healing and Promotes Angiogenesis in a Murine Ischemic Full Thickness Wound Model.	Talk	Plastic Surgery The Meeting	2016	Los Angeles, California
Phyllanthus emblica in cardioprotection. 8th International Symposium of Ayurveda and Health. Health, Immunity &Inflammation: Integrating Ancient Approaches with Modern Concepts.	Talk	University of Connecticut	2016	Farmington, CT
Various In Vivo Ischemic MOdels to Study Therapeutic Angiogenesis	Lecture	University of Connecticut Health, Surgery	2015	Department of Surgery
Adeno-Thioredoxin- 1 Delivery Improves Neovascularization in a Murine Model of Hind Limb Ischemia.	Talk	Surgical Congress	2015	Las Vegas
Improving Left Ventricular Function and Angiogenesis after MI in Flk Knock Out Mice with Intramyocardial Gene Therapy with Pellino1, a Novel Molecule in VEGF Signaling Pathway	Talk	New England Surgical Society	2015
Pellino 1 Gene Therapy Shows Novel Proangiogenic Function by Improving Survivability of Ischemic Skin Flap Tissue in Flk-1 Knockout Mice via NO/HO-1 Signaling Cascade.	Talk	New England Surgical Society	2015
Severe Necrosis of Ischemic Skin Flap Tissue in Flk-1+/- (Vascular Endothelial Growth Factor R2/KDR) Knockout Mice Treated with Pellino 1 (Peli1) Gene Therapy.	Talk	The American College of Surgeons	2015	Chicago, IL
Key players in cardiac and peripheral artery disease: potentials and challenges	Lecture	Institute of Cellular and System Medicine, National Health Research Inst.	2015	Zhunan, Taiwan
Silencing of prolylhydroxylases in cardiac and peripheral artery disease: potentials and challenges	Plenary Lecture	National Cheng Kung University, Taiwan	2015	Tainan, Taiwan
Key players in Cardiac Disease: Potential and Challenges	Plenary Lecture	11th International Symposium on Pharmaceutical Sciences, Ankara, Turke	2015	Ankara University, Turkey
Key Players in Myocardial Angiogenesis: Potential and Challenges	Lecture	Internationl Academy of Cardiovascular Sciences: North American Section	2015	Creighton University, Omaha, Nebraska
New Molecular Targets of VEGF Signaling in Cardiovascular Disease	Lecture	Institute for heart Research, Slovak Academy of Scences	2015	Bratislava, Slovak Republic
Silencing of Prolylhydroxylases in Cardiac Repair: Potential and Challenges	Plenary Lecture	International Academy of Cardiology: 19th World Congress on Heart Disease,	2014	Boston, MA
Key Players in Cardiac & Peripheral Artery Disease: Potential and Challenges	Lecture	2nd Cardiovascular Forum for Promoting Centers of Excellence and Young Inve	2014	Winnipeg, Manitoba, Canada
Key Players in Cardiac & Peripheral Artery Disease: Potential and Challenges	Lecture	41st National Conference of Association of Clinical Biochemists of India	2014	Jodhpur, India
SILENCING OF PROLYLHYDROXYLASES IN CARDIAC REPAIR: POTENTIAL AND CHALLENGES	Other		2013	East Virginia
SILENCING OF PROLYLHYDROXYLASES IN CARDIAC REPAIR: POTENTIAL AND CHALLENGES	Plenary Lecture	Clinical Conference	2013	Kalyani, India
SILENCING OF PROLYLHYDROXYLASES IN CARDIAC REPAIR: POTENTIAL AND CHALLENGES	Lecture	The Cardiovascular Forum for Promoting Centers of Excellence and Young Inve	2013	Louisville, KY
Symposium	Other	Clinical Conference	2013	Kalyani, India
Symposium	Other	The Cardiovascular Forum for Promoting Centers of Excellence and Young Inve	2013	Louisville, KY
THIOREDOXIN-1 GENE THERAPY FOR CARDIOVASCULAR DISEASE	Lecture	International Academy of Cardiology: 18th World Congress on Heart Disease,	2013	Vancouver, B.C., Canada
Inhibition of Prolyl Hydroxylases: a Novel therapy for Peripheral Arterial and Cardiovascular Diseases	Plenary Lecture	25th Annual Conference of The Indian Society for Atherosclerosis Research	2012	Annamalai nagar, Tamilnadu, India
Silencing of Prolylhydroxylases in Cardiac and Peripheral artery disease: Potential and Challenges	Plenary Lecture	International Meet on Advanced Studies in Cell Signaling Network (CESIN 201	2012	Kolkata, India
Diabetes-mediated impairment of angiogenesis in myocardial injury	Lecture	53rd Annual American College of Nutrition	2012	Morristown, NJ
Silencing of prolyl hydroxylases in cardiac Repair: Potential and challenges	Lecture	International Conference on Recent Trends in Therapeutic advancement of Fre	2011	Chennai, India
Silencing of prolyl hydroxylases in cardiac Repair: Potential and challenges.	Lecture	4th World Congress of international Academy of Cardiovascular Sciences	2011	Vadodara, India
Resveratrol expanding roles in cardiovascular disorders	Lecture	8th International Conference of Functional Foods a	2011	Las Vegas, Nevada
Rescue of diabetes related impairment of myocardial angiogenesis: Potential and challenges	Lecture	Heart Institute and Cardiovascular Research Center’s	2011	Lexington, KY
Silencing of prolyl hydroxylases in cardiac Repair: Potential and challenges	Lecture	Winnipeg Heart International Conference	2011	Winnipeg, Canada
Thereapeutic Angiogenesis: Treating the coronary Vessel disease with genes and Gene products	Lecture	97th Indian Science Congress	2010	Trivandrum, Kerala, India
Rejuvenating the failing heart: Messenchymal stem cells making headway towards clinics	Lecture	Society for Free Radical Research-India Satellite Conference	2010	Thrissur, Kerala, India
Rescue of diabetes related impairment of myocardial angiogenesis: Potential and challenges	Lecture	International Conference on Advances in Free Radical Research, Natural products, Antioxidants and Ra	2010	Hydrabad, India
Rescue of diabetes related impairment of myocardial angiogenesis: Potential and challenges	Lecture	OCC 2010 World Congress on Translational Redox and Tissue Oxygen Biology	2010	Santa Barbara, California